Anick Auger

500 total citations
19 papers, 378 citations indexed

About

Anick Auger is a scholar working on Molecular Biology, Infectious Diseases and Virology. According to data from OpenAlex, Anick Auger has authored 19 papers receiving a total of 378 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 6 papers in Infectious Diseases and 4 papers in Virology. Recurrent topics in Anick Auger's work include HIV Research and Treatment (4 papers), HIV/AIDS drug development and treatment (4 papers) and Toxin Mechanisms and Immunotoxins (3 papers). Anick Auger is often cited by papers focused on HIV Research and Treatment (4 papers), HIV/AIDS drug development and treatment (4 papers) and Toxin Mechanisms and Immunotoxins (3 papers). Anick Auger collaborates with scholars based in Canada, United States and France. Anick Auger's co-authors include Roman A. Melnyk, Greg L. Beilhartz, John Tam, Pulkit Gupta, Alex G. Therien, Louise Brissette, D. Borden Lacy, Guila Dayan, Francine Denizeau and Walter Rocha and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Biochemistry.

In The Last Decade

Anick Auger

18 papers receiving 374 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anick Auger Canada 11 172 121 86 75 63 19 378
Geneviève Doyon United States 11 196 1.1× 125 1.0× 95 1.1× 123 1.6× 83 1.3× 18 527
Chirag Dhar United States 9 204 1.2× 100 0.8× 100 1.2× 31 0.4× 57 0.9× 21 396
Valentina Guerrini United States 8 115 0.7× 129 1.1× 78 0.9× 28 0.4× 60 1.0× 23 347
Chuan Young Ng Singapore 8 208 1.2× 87 0.7× 47 0.5× 37 0.5× 26 0.4× 10 462
Rachel L. Cooper United States 7 168 1.0× 56 0.5× 68 0.8× 48 0.6× 178 2.8× 10 390
Austin W.T. Chiang United States 17 466 2.7× 57 0.5× 127 1.5× 85 1.1× 103 1.6× 43 720
Anusha Hettiaratchi Australia 7 199 1.2× 118 1.0× 37 0.4× 66 0.9× 23 0.4× 8 369
Elizabeth Cauchon Canada 8 159 0.9× 101 0.8× 50 0.6× 27 0.4× 17 0.3× 11 384
Charles S. Johnson United States 10 142 0.8× 48 0.4× 36 0.4× 47 0.6× 20 0.3× 15 306

Countries citing papers authored by Anick Auger

Since Specialization
Citations

This map shows the geographic impact of Anick Auger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anick Auger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anick Auger more than expected).

Fields of papers citing papers by Anick Auger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anick Auger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anick Auger. The network helps show where Anick Auger may publish in the future.

Co-authorship network of co-authors of Anick Auger

This figure shows the co-authorship network connecting the top 25 collaborators of Anick Auger. A scholar is included among the top collaborators of Anick Auger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anick Auger. Anick Auger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Auger, Anick, Rei Ono, Amandine Chefson, et al.. (2025). Post-symptomatic NLRP3 inhibition rescues cognitive impairment and mitigates amyloid and tau driven neurodegeneration. PubMed. 1(1). 3–3. 3 indexed citations
2.
Wasney, Gregory A., John Tam, Anick Auger, et al.. (2023). Small Molecule Inhibition of an Exopolysaccharide Modification Enzyme is a Viable Strategy To Block Pseudomonas aeruginosa Pel Biofilm Formation. Microbiology Spectrum. 11(3). e0029623–e0029623. 8 indexed citations
3.
4.
Lai, Ming‐Tain, Paul Tawa, Anick Auger, et al.. (2017). Identification of novel bifunctional HIV-1 reverse transcriptase inhibitors. Journal of Antimicrobial Chemotherapy. 73(1). 109–117. 6 indexed citations
5.
Tam, John, Greg L. Beilhartz, Anick Auger, et al.. (2015). Small Molecule Inhibitors of Clostridium difficile Toxin B-Induced Cellular Damage. Chemistry & Biology. 22(2). 175–185. 57 indexed citations
6.
Auger, Anick, Felix Nitschké, Lori M. Minassian, et al.. (2015). Efficient Delivery of Structurally Diverse Protein Cargo into Mammalian Cells by a Bacterial Toxin. Molecular Pharmaceutics. 12(8). 2962–2971. 37 indexed citations
7.
Bernatchez, Jean, R. J. Paul, Egor P. Tchesnokov, et al.. (2014). Derivatives of Mesoxalic Acid Block Translocation of HIV-1 Reverse Transcriptase. Journal of Biological Chemistry. 290(3). 1474–1484. 14 indexed citations
8.
Tam, John, et al.. (2014). Translocation domain mutations affecting cellular toxicity identify the Clostridium difficile toxin B pore. Proceedings of the National Academy of Sciences. 111(10). 3721–3726. 51 indexed citations
9.
Auger, Anick, Greg L. Beilhartz, Elizabeth Cauchon, et al.. (2011). Impact of Primer-induced Conformational Dynamics of HIV-1 Reverse Transcriptase on Polymerase Translocation and Inhibition. Journal of Biological Chemistry. 286(34). 29575–29583. 2 indexed citations
10.
Cauchon, Elizabeth, Jean‐Pierre Falgueyret, Anick Auger, & Roman A. Melnyk. (2011). A High-Throughput Continuous Assay for Screening and Characterization of Inhibitors of HIV Reverse-Transcriptase DNA Polymerase Activity. SLAS DISCOVERY. 16(5). 518–524. 9 indexed citations
11.
Toulmond, Sylvie, Anick Auger, Christoph A. Binkert, et al.. (2011). Characterization of a stable, hypertensive rat model suitable for the consecutive evaluation of human renin inhibitors. Journal of the Renin-Angiotensin-Aldosterone System. 12(3). 133–145. 5 indexed citations
12.
Pulichino, Anne-Marie, I‐Ming Wang, Alexandre Caron, et al.. (2008). Identification of Transforming Growth Factor β1–Driven Genetic Programs of Acute Lung Fibrosis. American Journal of Respiratory Cell and Molecular Biology. 39(3). 324–336. 44 indexed citations
13.
Lupien, Mathieu, M. Jeyakumar, Khalid Hilmi, et al.. (2007). Raloxifene and ICI182,780 Increase Estrogen Receptor-α Association with a Nuclear Compartment via Overlapping Sets of Hydrophobic Amino Acids in Activation Function 2 Helix 12. Molecular Endocrinology. 21(4). 797–816. 36 indexed citations
14.
Dayan, Guila, Mathieu Lupien, Anick Auger, et al.. (2006). Tamoxifen and Raloxifene Differ in Their Functional Interactions with Aspartate 351 of Estrogen Receptor α. Molecular Pharmacology. 70(2). 579–588. 29 indexed citations
15.
Rocha, Walter, Rocío Sánchez, Julie Deschênes, et al.. (2005). Opposite Effects of Histone Deacetylase Inhibitors on Glucocorticoid and Estrogen Signaling in Human Endometrial Ishikawa Cells. Molecular Pharmacology. 68(6). 1852–1862. 15 indexed citations
16.
Seguin, Laetitia, Caroline Liot, Anick Auger, et al.. (2005). Regulation of Rho signaling pathways in interleukin‐2‐stimulated human T‐lymphocytes. The FASEB Journal. 19(13). 1911–1913. 19 indexed citations
17.
Auger, Anick, et al.. (2001). Low and high density lipoprotein metabolism in primary cultures of hepatic cells from normal and apolipoprotein E knockout mice. European Journal of Biochemistry. 268(8). 2322–2330. 13 indexed citations
18.
Auger, Anick, et al.. (2000). Analysis of low-density lipoprotein catabolism by primary cultures of hepatic cells from normal and low-density lipoprotein receptor knockout mice. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1484(2-3). 307–315. 23 indexed citations
19.
Tremblay, Caroline, Éric Rassart, David Rhainds, et al.. (2000). Low- and High-Density Lipoprotein Metabolism in HepG2 Cells Expressing Various Levels of Apolipoprotein E. Biochemistry. 39(51). 16084–16091. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Geneviève Doyon Breakdown of academic impact, for papers by Chirag Dhar Breakdown of academic impact, for papers by Valentina Guerrini Breakdown of academic impact, for papers by Chuan Young Ng Breakdown of academic impact, for papers by Rachel L. Cooper Breakdown of academic impact, for papers by Austin W.T. Chiang Breakdown of academic impact, for papers by Anusha Hettiaratchi Breakdown of academic impact, for papers by Elizabeth Cauchon Breakdown of academic impact, for papers by Charles S. Johnson
Rankless by CCL
2026